Dr. Risa Naomi Fuller, MD

Dr. Fuller practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Fuller's NPI, 1497175863, was assigned on April 23, 2014. Dr. Fuller graduated from State University of New York Downstate Medical Center in 2014. Dr. Fuller holds New York license 291562-1.

Dr. Fuller's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Fuller also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Fuller's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Fuller to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fuller practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Fuller's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Fuller is licensed in New York.

CMS data shows 323 Medicare services from Dr. Fuller across 4 procedure codes in 2024, for 142 Medicare patients. Medicare paid $34,683 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 142 Medicare patients who saw Dr. Fuller in 2024. The largest group is 65 to 74, with 66 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 44% are also on Medicaid. Their average risk score is 4.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fuller's median patient age at 58, with 44% women.

In 2024, Dr. Fuller wrote 57 Medicare Part D claims for 32 patients. 91% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $119 in total drug cost. In 2019, CMS named 62 claims across 4 drugs.

Dr. Fuller accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fuller as offering telehealth.

Dmand AI links 13 papers to Dr. Fuller, published from 2019 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Anti-Bacterial Agents, Hematopoietic Stem Cell Transplantation and Kidney Transplantation. Dr. Fuller has published most often in Transpl Infect Dis. Dr. Fuller's most frequent co-authors are Meenakshi Mehrotra Rana, MD, Dallas F. Dunn and Sarah Taimur, MD.

Dr. Fuller graduated from State University of New York Downstate Medical Center in 2014.